Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Can Fite Biopharma Ltd ADR (CANF) stocks
Learn how to easily invest in Can Fite Biopharma Ltd ADR stocks.
Can Fite Biopharma Ltd ADR is a biotechnology business based in the US. Can Fite Biopharma Ltd ADR stocks (CANF.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $2.32 – an increase of 19.64% over the previous week. Can Fite Biopharma Ltd ADR employs 8 staff and has a trailing 12-month revenue of around $810,000.
How to buy Can Fite Biopharma Ltd ADR stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CANF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Can Fite Biopharma Ltd ADR?
- Has coronavirus impacted Can Fite Biopharma Ltd ADR shares?
- Can Fite Biopharma Ltd ADR shares summary
- Compare share dealing platforms
- Is Can Fite Biopharma Ltd ADR stock a buy or sell?
- Can Fite Biopharma Ltd ADR performance over time
- Can Fite Biopharma Ltd ADR's financials
- How volatile are Can Fite Biopharma Ltd ADR shares?
- Does Can Fite Biopharma Ltd ADR pay a dividend?
- Have Can Fite Biopharma Ltd ADR shares ever split?
- Other common questions
Can Fite Biopharma Ltd ADR stock price (NYSE MKT:CANF)Use our graph to track the performance of CANF stocks over time.
Can Fite Biopharma Ltd ADR shares at a glance
|Latest market close||$2.68|
|52-week range||$1.52 - $11.20|
|50-day moving average||$2.07|
|200-day moving average||$5.53|
|Wall St. target price||$40.83|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.95|
Buy Can Fite Biopharma Ltd ADR stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Can Fite Biopharma Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Can Fite Biopharma Ltd ADR price performance over time
Historical closes compared with the close of $2.68 from 2023-06-01
|1 week (2023-05-26)||19.64%|
|1 month (2023-05-03)||39.58%|
|3 months (2023-03-03)||-1.11%|
|6 months (2022-12-02)||219.05%|
|1 year (2022-06-03)||182.11%|
|2 years (2021-06-03)||28.85%|
|3 years (2020-06-03)||31.37%|
|5 years (2018-06-01)||97.06%|
Can Fite Biopharma Ltd ADR financials
|Gross profit TTM||$810,000|
|Return on assets TTM||-42.73%|
|Return on equity TTM||-107.91%|
|Market capitalisation||$9.1 million|
TTM: trailing 12 months
Can Fite Biopharma Ltd ADR share dividends
We're not expecting Can Fite Biopharma Ltd ADR to pay a dividend over the next 12 months.
Have Can Fite Biopharma Ltd ADR's shares ever split?
Can Fite Biopharma Ltd ADR's shares were split on a 1:10 basis on 9 January 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Can Fite Biopharma Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Can Fite Biopharma Ltd ADR shares which in turn could have impacted Can Fite Biopharma Ltd ADR's share price.
Can Fite Biopharma Ltd ADR share price volatility
Over the last 12 months, Can Fite Biopharma Ltd ADR's shares have ranged in value from as little as $1.52 up to $11.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Can Fite Biopharma Ltd ADR's is 0.8014. This would suggest that Can Fite Biopharma Ltd ADR's shares are less volatile than average (for this exchange).
Can Fite Biopharma Ltd ADR overview
Can-Fite BioPharma Ltd. , a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases.
Stocks similar to Can Fite Biopharma Ltd ADR
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Best bad credit loans in Prince Edward Island
Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
Guide to finding the best prepaid card in Canada in June 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.